DC10339 |
Vadadustat
|
Vadadustat is a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor in development for the treatment of anemia. |
DC7486 |
PX-478 2HCL
|
PX-478 is an inhibitor of HIF-1a with an IC50 of 20-30μM enhances radiosensitivity of prostate carcinoma cells. |
DC10464 |
PT2385
|
PT2385 is an orally active, small molecule inhibitor of hypoxia inducible factor (HIF)-2alpha, with potential antineoplastic activity. |
DC8390 |
Oltipraz
|
Oltipraz is a potent Nrf2 activator and a potent inducer of Phase II detoxification enzymes, most notably glutathione-S-transferase (GST). Phase 3. |
DC12043 |
KHS-101
|
KHS101 is a selective inducer of neuronal differentiation; induces neuronal differentiation in cultured hippocampal neural progenitor cells (NPCs) by interacting with TACC3 (EC50 ~1 μM). |
DC8447 |
KC7F2
|
KC7F2 is a potent HIF-1 pathway inhibitor and that its potential as a cancer therapy agent warrants further study. |
DC8617 |
JNJ-42041935
|
JNJ-42041935 is a potent (pKi = 7.3-7.9), 2-oxoglutarate competitive, reversible, and selective inhibitor of PHD enzymes. |
DC10825 |
IOX4
|
IOX4 is a potent inhibitor of PHD2 (IC50 = 1.6 nM). |
DC8166 |
Molidustat(BAY 85-3934)
|
Hypoxia-inducible factor prolyl hydroxylase inhibitor |
DC5193 |
Roxadustat(FG-4592)
|
FG-4592 is an HIF αprolyl hydroxylase inhibitor, stabilizes HIF-2 and induces EPO production. |